Neupogen 600 mcg (Filgrastim SOLUTION) 600 MCG

NEUPOGEN 600 MCG is a solution containing filgrastim, used to stimulate the production of white blood cells. This intravenous medication supports the immune system during certain medical treatments.

Strength

600 MCG

Pack Size

0.5ML

Manufacturer / TM Owner

AMGEN CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NEUPOGEN 600 MCG is primarily used to boost white blood cell counts in individuals undergoing treatments that may suppress the immune system. It is often administered to patients receiving chemotherapy or those with certain blood disorders. The active ingredient, filgrastim, works by stimulating the bone marrow to produce more white blood cells, which are crucial for fighting infections.

Side Effects

Common effects of NEUPOGEN 600 MCG may include mild bone pain, headaches, and fatigue. Some individuals might experience swelling or redness at the injection site. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Precautions & Warnings

NEUPOGEN 600 MCG should be handled with care and administered under medical supervision. It is important to inform healthcare providers about any allergies or existing medical conditions before use. Proper storage and handling instructions should be followed to maintain the medication's effectiveness.

Avoid Interactions

NEUPOGEN 600 MCG may interact with other medications, particularly those that affect the immune system. It is advisable to consult with a healthcare provider before combining it with other treatments. Alcohol and certain supplements might also influence its effects, so caution is recommended.

Frequently Asked Questions

NEUPOGEN 600 MCG is used to stimulate the production of white blood cells, often in patients undergoing treatments that may suppress the immune system.

NEUPOGEN 600 MCG is administered intravenously, typically under medical supervision.

Common side effects may include bone pain, headaches, and fatigue. These effects are usually temporary.

It is important to consult with a healthcare provider before combining NEUPOGEN 600 MCG with other medications, as interactions may occur.

NEUPOGEN 600 MCG should be stored according to the manufacturer's instructions to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.